Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond T P Lin

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
The Journal of Infectious Diseases|September 4, 2020
Exportation of Monkeypox Virus From the African ContinentMatthew R Mauldin, Andrea M McCollum, Yoshinori J Nakazawa, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Nature Communications|November 17, 2022
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
The Journal of Infectious Diseases|September 4, 2020
Exportation of Monkeypox Virus From the African ContinentMatthew R Mauldin, Andrea M McCollum, Yoshinori J Nakazawa, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Nature Communications|November 17, 2022
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Pageof 10